Chemours Reports Shareholder Vote Results

Ticker: CC · Form: 8-K · Filed: 2024-05-23T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, shareholder-meeting, auditor-ratification

Related Tickers: CC

TL;DR

Chemours shareholders voted on directors and auditors; results are in.

AI Summary

On May 21, 2024, The Chemours Company filed an 8-K to report on matters submitted to a vote of its security holders. The filing details the outcomes of a shareholder meeting, including the election of directors and the ratification of PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2024.

Why It Matters

This filing provides transparency on key corporate governance decisions made by Chemours' shareholders, including the composition of its board and the oversight of its financial auditing.

Risk Assessment

Risk Level: low — This is a routine corporate filing detailing shareholder votes and has no immediate financial implications.

Key Players & Entities

FAQ

What was the primary purpose of this 8-K filing?

The primary purpose was to report on matters submitted to a vote of The Chemours Company's security holders, specifically detailing the outcomes of a shareholder meeting.

When was the earliest event reported in this filing?

The earliest event reported was on May 21, 2024.

Who was ratified as Chemours' independent registered public accounting firm?

PricewaterhouseCoopers LLP was ratified as Chemours' independent registered public accounting firm for the fiscal year ending December 31, 2024.

What is Chemours' state of incorporation?

The Chemours Company is incorporated in Delaware.

What is the principal executive office address for Chemours?

The principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.

From the Filing

0000950170-24-063967.txt : 20240523 0000950170-24-063967.hdr.sgml : 20240523 20240523162014 ACCESSION NUMBER: 0000950170-24-063967 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240521 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24978560 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20240521.htm 8-K 8-K 0001627223 false 0001627223 2024-05-21 2024-05-21     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   May 21, 2024 Date of Report (Date of Earliest Event Reported)   The Chemours Co mpany (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐           Item 5.07 Submission of Matters to a Vote of Security Holders. The Chemours Company (the “Company”) held its annual meeting of shareholders on May 21, 2024 (the “Annual Meeting”). At the Annual Meeting, shareholders: • elected all nine director nominees to serve a one-year term; • approved the Company’s annual “say-on-pay” vote on an advisory basis; and • ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm. The final voting results for each proposal were as follows: Proposal 1 – Election of Directors to Serve One-Year Term   Nominee For Against Abstain Broker Non-Votes Curtis V. Anastasio 107,037,011 (93.

View on Read The Filing